Bharati Pravin Pawar,Union Minister of State for Health and Family...
Category:
Health
Latest
ESIC extends medical benefits to superannuated insured persons with relaxed norms
The persons who were in the insurable employment for at least 5...
New India’s net profit at Rs 713 crore in Q3FY24 despite large Nat Cat losses
"FY24 continues to be a challenging year for the company. In the...
India gave priority to poor in its strategy to combat COVID-19 crisis: PM Modi
He noted that over 80 crore citizens have been provided free ration after the COVID-19 started in the country.
“Not just wheat, rice or pulses but over 8 crore poor families were even provided free gas cylinders during the lockdown. Over 20 crore women received around Rs 30,000 crores directly in their Jan Dhan bank accounts,” the Prime Minister stated.
Johnson & Johnson’s single-dose COVID-19 vaccine gets Emergency Use approval in India
The five vaccines granted Emergency Use Authorisation in India are Serum Institute’s Covishield, Bharat Biotech’s Covaxin, Russia’s Sputnik V, Moderna, and now Johnson & Johnson (J&J).
India sees single-day rise of 38,628 New Coronavirus cases, 617 fresh deaths
Cumulative vaccine doses administered so far has reached 50.10 crore under the nationwide vaccination drive
United States now averaging 100,000 new Covid-19 infections a day
The virus is spreading quickly through unvaccinated populations, especially in the Deep South. Florida, Louisiana and Mississippi have had hospitals overrun with patients.
The US first crossed the 100,000 average number in November and peaked at about 250,000 in early January before bottoming out in late June.
Heart, stroke risks climb after COVID-19; flu shots may be protective
In the week following a COVID-19 diagnosis, the risk of a first heart attack went up three- to eight-fold, and the risk of a first stroke due to a blood-vessel blockage rose three- to six-fold, the researchers found.
DST receives 478 proposals to study effects of yoga, meditation in fighting Covid
”During the year 2020-21, the department had announced a special call under SATYAM programme to combat with COVID-19 and related viruses in order to explore the effect of yoga and meditation as add on therapy under three broad thematic areas viz. immunity, respiratory system and stress, anxiety and depression, Science and Technology Minister Jitendra Singh said on Friday.,” ‘
South Korea to compensate nurse paralysed after Covid-19 shot
AstraZeneca has been granted protection from product liability claims related to its Covid-19 vaccine by most of the countries with which it has struck supply agreements.
After reports of a rare blood clots associated with the vaccine this year, several countries announced restrictions on its use in younger people.
In Asia, countries including Singapore, Australia, Thailand and Malaysia have financial assistance programmes or set up compensation funds for those who suffer serious side effects from vaccines.
No work, no food: Pandemic deepens global hunger
The World Food Program sounded the alarm further last week in a joint report with the UN’s Food and Agriculture Organization, warning that “conflict, the economic repercussions of Covid-19 and the climate crisis are expected to drive higher levels of acute food insecurity in 23 hunger hot spots over the next four months,” mostly in Africa but also Central America, Afghanistan and North Korea.
Downbeat Indian consumers withhold spending amid pandemic, says RBI survey
“The sentiments on overall spending remained unchanged as higher spending on essential items were offset by a drop in non-essential expenditure with consumers expecting further contraction in discretionary expenditure in the year ahead,” the RBI said.
With forecasters warning of a third wave, any new restrictions could spell more bad news for the country, where private consumption makes up some 60% of gross domestic product.
J&J seeks emergency use nod for COVID-19 vaccine in India
Indian health authorities have so far approved the use of vaccines developed by AstraZeneca, Bharat Biotech, Russia’s Gamaleya Institute and Moderna.
The government and Moderna are still trying to sort out issues over imports of the vaccine and indemnity, a top executive at Indian drugmaker and Moderna’s local distribution partner Cipla told Reuters in an interview on Friday.